WUXI BIOLOGICS USA LLC

WUXI BIOLOGICS USA LLC filed a Q3 report for WUXI BIOLOGICS USA LLC on October 17, 2025.

Lobbying for WUXI BIOLOGICS USA LLC · A global contract research, development, and manufacturing organization for biologics.

All filings by WUXI BIOLOGICS USA LLC · Everything WUXI BIOLOGICS USA LLC has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 17, 2025

Expenses

$100,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New Jersey

Official filing document

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Lobbying related to Congressional and Administration introductions and company updates, communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.